Jan Visser

Pontifical Urban University IT

188

Publications

6,035

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

A fully automatic program for finding the unit cell from powder data

Jan Visser

Journal of Applied Crystallography 1969

987

SSEA-4 identifies mesenchymal stem cells from bone marrow

Eun Ji Gang, Darko Bosnakovski, Camila Alexandrina Figueiredo, Jan Visser, Rita C. R. Perlingeiro

Blood 2006

499

Isolation of murine pluripotent hemopoietic stem cells. OA

Jan Visser, J. G. J. Bauman, A Mulder, James F. Eliason, A.M. de Leeuw

The Journal of Experimental Medicine 1984

333

In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population

Ben A. Scheven, Jan Visser, Peter J. Nijweide

Nature 1986

269

Automatic collection of powder data from photographs

E.J. Sonneveld, Jan Visser

Journal of Applied Crystallography 1975

226

Publications

187 total

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013 OA

A. D. Da Silva, U. Kronthaler, Vera Koppenburg, M. Fink, I. Meyer - Leukemia and Lymphoma, 2014

Cited by 45 Semantic Scholar

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab OA

J. Visser, I. Feuerstein, T. Stangler, Timo Schmiederer, C. Fritsch - BioDrugs, 2013

Cited by 179 Semantic Scholar

Physicochemical, functional, and pharmacologic comparability between the proposed biosimilar rituximab GP2013 and originator rituximab as the foundation for biosimilarity.

Antonio da Silva, U. Kronthaler, I. Meyer, C. Fritsch, Timo Schneiderer - Unknown Venue, 2013

Cited by 3 Semantic Scholar

AB1403 Comprehensive target-directed approach for the development of a highly-comparable rituximab biosimilar

A. D. Da Silva, R. Grau, T. Stangler, H. Summer, I. Meyer - Unknown Venue, 2013

Cited by 2 Semantic Scholar

Target-Directed Development of a Proposed Biosimilar Rituximab (GP2013): Comparability of Antibody-Dependent Cellular Cytotoxicity Activity and Pre-Clinical Pharmacokinetics and Pharmacodynamics with Originator Rituximab

Antonio da Silva, U. Kronthaler, I. Meyer, A. Papandrikopoulou, T. Stangler - Unknown Venue, 2012

Cited by 4 Semantic Scholar

SSEA-4 identifies mesenchymal stem cells from bone marrow

Eun Ji Gang, Darko Bosnakovski, Camila Alexandrina Figueiredo, Jan Visser, Rita C. R. Perlingeiro - Blood, 2006

Cited by 499 OpenAlex

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells PDF

Mecheal Kanovsky, Anthony J. Raffo, Lisa Drew, Ramon Rosal, Tamara Do et al. - Proceedings of the National Academy of Sciences, 2001

Cited by 89 OpenAlex

The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells PDF

J. M. J. M. Zijlmans, Jan Visser, L. Laterveer, Karin Kleiverda, Diana P. M. Heemskerk et al. - Proceedings of the National Academy of Sciences, 1998

Cited by 105 OpenAlex

Homing of fluorescently labeled murine hematopoietic stem cells.

P J Hendrikx, C M Martens, Anton Hagenbeek, J.F.K. Keij, Jan Visser - PubMed, 1996

Cited by 193 OpenAlex

Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. OA

J. M. J. M. Zijlmans, Jan Visser, Karin Kleiverda, P. M. Kluin, Roel Willemze et al. - Proceedings of the National Academy of Sciences, 1995

Cited by 99 OpenAlex

Research Topics

Mesenchymal stem cell research (23) Hematopoietic Stem Cell Transplantation (23) Pluripotent Stem Cells Research (12) X-ray Diffraction in Crystallography (12) Photosynthetic Processes and Mechanisms (10)

Frequent Co-Authors

A Mulder

2 joint publications

E.J. Sonneveld

2 joint publications

J. M. J. M. Zijlmans

2 joint publications

Karin Kleiverda

2 joint publications

Roel Willemze

2 joint publications

Willem E. Fibbe

2 joint publications

Affiliations

Leiden University

NL 1986 - 1972

Hudson Institute

US 2017 - 2017

New York Blood Center

US 2007 - 1991

Netherlands Organisation for Applied Scientific Research

NL 1996 - 1979

Utrecht University

NL 2003 - 1993

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Jan Visser

Publication & Citation Trends

Most Cited Works

Publications

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013 OA

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab OA

Physicochemical, functional, and pharmacologic comparability between the proposed biosimilar rituximab GP2013 and originator rituximab as the foundation for biosimilarity.

AB1403 Comprehensive target-directed approach for the development of a highly-comparable rituximab biosimilar

Target-Directed Development of a Proposed Biosimilar Rituximab (GP2013): Comparability of Antibody-Dependent Cellular Cytotoxicity Activity and Pre-Clinical Pharmacokinetics and Pharmacodynamics with Originator Rituximab

SSEA-4 identifies mesenchymal stem cells from bone marrow

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells PDF

The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells PDF

Homing of fluorescently labeled murine hematopoietic stem cells.

Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. OA

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back